Neuralstem, Inc. announced, in furtherance of its reorganization plans and focus on clinical development, that Richard Daly, the company’s president and chief executive officer, has been appointed as chairman of the board of directors. Mr. Daly’s appointment as chairman will allow Dr. Karl Johe, the company’s founder, chief scientific officer and former chairman, to focus exclusively on the development of the company’s product candidates.